A Pharmacist’s Guide to the Use of Novel Therapies for the Treatment of Patients With Prostate Cancer
On-Demand Free CE-accredited Webinar!
This activity is supported by an educational grant from
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and CURE Media Group.
This activity is jointly sponsored by
Rutgers Biomedical and Health Sciences, Ernest Mario School of Pharmacy.
Faculty Presenter
Katie P. Morgan, PharmD, BCOP, CPP
Clinical Pharmacist Practitioner, GU and Neuro Oncology
PGY2 Oncology Pharmacy Residency Coordinator
University of North Carolina (UNC) Medical Center
Assistant Professor of Clinical Education
UNC Eshelman School of Pharmacy
Chapel Hill, North Carolina
Program Description
Prostate cancer is common and accounts for 20% of all new cancer diagnoses in men. Genetic testing and risk stratification play a major role in predicting prognosis and developing a treatment strategy for patients with prostate cancer. A variety of treatment options continue to evolve, including surgery, radiation, hormonal agents, cytotoxic chemotherapy, and oral oncolytics, and are utilized sometimes in combination based on patient and disease characteristics. A balance between disease control and mitigation of adverse effects is important. This program will explore germline mutations associated with prostate cancer and the multiple factors involved in risk stratification to enable pharmacists to educate patients, manage adverse effects, enhance adherence, and evaluate individual therapeutic effectiveness related to a selected treatment regimen.
Target Audience: Health-system pharmacists, specialty pharmacists, and oncology pharmacists
Release Date: October 7, 2020
Expiration Date: April 7, 2022
Activity Fee: Free
Activity Type: Application
Estimated Time to Complete Activity: 1.0 hour
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the influence germline testing and risk stratification have on therapy selection for patients receiving treatment for prostate cancer
- Analyze a treatment regimen for a patient with prostate cancer based on treatment guideline suggestions along with patient- and disease-specific characteristics
- Identify the ways in which pharmacists can intervene in the care of patients receiving treatment for prostate cancer to maximize treatment outcomes
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-20-305-H01-P. The activity is available for CE credit through April 7, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Katie P. Morgan, PharmD, BCOP, CPP, has no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy Seung, PharmD, BCOP, FHOPA; Meg Taylor, PharmD, CPP; Crissy Wilson; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Activity Disclaimer
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this live CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
